Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Then something changed
Jun Guo and Eric Chung designed the review, supervised all figures, and cowrote the manuscript
CAS: 170851-70-4
What can your company expect
Consult a healthcare professional before conducting research on these compounds
GLP-1 treatment was not statistically significantly different compared to control at reducing the risk of developing dry AMD at one and three years after treatment, but GLP-1 receptor agonists did lower dry AMD risk at five and 10 years after treatment by 9.2% and 14.9%, respectively
US$ 24.51
US$ 29.63
US$ 22.73
US$ 28.06
US$ 28.99
US$ 29.79
